🇺🇸 FDA
Pipeline program

RO7034067, Evrysdi 0.75 mg/mL powder for oral solution

BN44620

Approved small_molecule active

Quick answer

RO7034067, Evrysdi 0.75 mg/mL powder for oral solution for Spinal Muscular Atrophy (SMA) is a Approved program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Roche Registration Limited
Indication
Spinal Muscular Atrophy (SMA)
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials